Elamipretide
Investigational — mitochondrial peptide — not approved.
What it's for
Investigational — mitochondrial peptide — not approved.
What it's for
Elamipretide (SS-31) is an still being studied 4–amino-acid peptide that associates with cardiolipin on the inner mitochondrial membrane.
What it does for the body
Studied in Barth syndrome, mitochondrial myopathy, heart failure, and related conditions. Not FDA-approved. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Proposed to stabilize cardiolipin and improve electron-transport efficiency / reduce oxidative damage in dysfunctional mitochondria. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Elamipretide is still being studied in people. Watch for peer-reviewed trial readouts and regulator decisions — not just social-media summaries.
Studied for (literature interest)
- Hormones research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Elamipretide — FDA.gov search
- ClinicalTrials.gov search: Elamipretide — U.S. clinical trials registry
- Drugs@FDA search: Elamipretide — FDA drug database (if approved)
- PubMed search: Elamipretide — NCBI PubMed
- PubMed Central search: Elamipretide — NCBI PMC